My NCBISign In

Display Settings:

Format

Send to:

Choose Destination

    Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11810-3.

    Human neoplasms elicit multiple specific immune responses in the autologous host.

    Sahin U, Türeci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M.

    Medizinische Klinik und Poliklinik, Innere Medizin I, University of Saarland Medical School, Homburg, Germany.

    Expression of cDNA libraries from human melanoma, renal cancer, astrocytoma, and Hodgkin disease in Escherichia coli and screening for clones reactive with high-titer IgG antibodies in autologous patient serum lead to the discovery of at least four antigens with a restricted expression pattern in each tumor. Besides antigens known to elicit T-cell responses, such as MAGE-1 and tyrosinase, numerous additional antigens that were overexpressed or specifically expressed in tumors of the same type were identified. Sequence analyses suggest that many of these molecules, besides being the target of a specific immune response, might be of relevance for tumor growth. Antibodies to a given antigen were usually confined to patients with the same tumor type. The unexpected frequency of human tumor antigens, which can be readily defined at the molecular level by the serological analysis of autologous tumor cDNA expression cloning, indicates that human neoplasms elicit multiple specific immune responses in the autologous host and provides diagnostic and therapeutic approaches to human cancer.

    PMID: 8524854 [PubMed - indexed for MEDLINE]

    PMCID: PMC40492

    Supplemental Content

    Click here to read
    Write to the Help Desk